GRPN · Groupon, Inc. · Stock research

.# GRPN — Groupon, Inc.

Current Thesis

The break condition carried in the prior note — a weekly close below $20 — registered on 2026-08-21 at $19.59. That is the second structural level to fail in eight sessions: the mid-July shelf near $22 went on the 2026-08-14 weekly close of $21.51, and the round number went the following Friday. The 2026-08-06 Q2 print was the binary, and it resolved without a top-line inflection (revenue $124.675M versus $127.094M consensus, global revenue and global billings each −1% YoY, Q3 revenue guided to $128–130M against $131.9M consensus). What is left is a $796.63M market capitalisation on 40.67M shares (stockanalysis.com, 2026-08-23), a heavily shorted micro-cap float, and no scheduled company event inside the next 30 days.

The positioning picture moved the wrong way for anyone holding the covering thesis. Providers now report 13.73M shares short at 74.72% of float and 9.20 days to cover (stockanalysis.com, retrieved 2026-08-23), against the 10.93M shares reported by GuruFocus in the prior August reading. Float definitions differ between providers, so the percentage is not comparable across sources; the direction of the share count is. The short base built into a 21%-plus drawdown rather than covering it.

The narrative is dead. Dated by four observables: the 2026-08-06 print delivered a revenue miss and a below-consensus Q3 guide; the 2026-08-14 weekly close lost the $22 shelf; the 2026-08-21 weekly close of $19.59 lost $20; and the reported short base rose to 13.73M shares instead of covering. The label only changes on a weekly close reclaiming the $22 area alongside Q3 billings printing inside the guided +4–6%.

Bullish and bearish views on Groupon, Inc.

The model's bull view on Groupon, Inc. (GRPN), in brief: RSI(14) printed 4.6 on 2026-08-21. A reading that low means the 14-day window contains almost no net up-closes — a mechanical extreme, and in a name with 9.20 days to cover, the historical response to such conditions has been violent (2026-07-16 delivered a +10% single session… The bear view: Billings printed −1% YoY in both Q1 and Q2 2026 while FY26 guidance calls for +3–5%. Both cases follow in full.

Bull Case

• RSI(14) printed 4.6 on 2026-08-21. A reading that low means the 14-day window contains almost no net up-closes — a mechanical extreme, and in a name with 9.20 days to cover, the historical response to such conditions has been violent (2026-07-16 delivered a +10% single session on the Russell Value reclassification).
• Northland raised its target to $30 from $26 on 2026-08-17 and reiterated Buy, citing AI-driven efficiency — a target raise dated into the decline, not before it.
• Cash generation is dated and positive: Q2 2026 free cash flow +$15.0M and cash and equivalents $226.3M at 2026-06-30, with FY26 free cash flow guided to at least $60M and FY26 adjusted EBITDA held at $75–80M.
• The management vacancy created when COO Jiri Ponrt resigned effective 2026-07-10 was filled: Aditya Rajkumar was appointed Chief Operating Officer effective 2026-08-03, mid-restructuring.
• Active customers reached 16.1M in Q2 2026, +2% YoY, the user-side datapoint that the "Project Foundry" AI-native redesign is meant to compound against.
• Goldman Sachs' Sell-rated target of $22 (raised from $13, reported August 2026) now sits above the 2026-08-21 close of $19.59. The most bearish major house on the tape carries a number roughly 12% higher than where the stock trades.

Bear Case

• Billings printed −1% YoY in both Q1 and Q2 2026 while FY26 guidance calls for +3–5%. The entire year's growth is loaded into the second half, and the first instalment (Q3 billings +4–6%) does not report until the Q3 print.
• The balance sheet is not a net-cash story. Convertible principal outstanding was $290.281M at 2026-06-30 — including $244.071M of 4.875% convertible senior notes due 2030 issued 2025-07-02 — against $226.3M of cash on the same date.
• Q3 2026 free cash flow is guided negative while FY26 is guided to at least $60M, so the next cash print will look worse than the annual frame regardless of execution.
• The cost programme has not reached the reported line: Q2 adjusted EBITDA of $14.8M came in below the $15.6M of the prior-year quarter despite the up-to-400-role reduction announced in late May 2026.
• Sell-side dispersion spans $13 to $40 on 12-month targets. A range that wide across a $796.63M market capitalisation says the modelled outcomes are not converging.
• The 13.73M-share reported short base is not purely directional. With $290.281M of converts outstanding, some portion is plausibly convertible-arbitrage hedging — an inference, not a measured split — which would mean less mechanical covering pressure than the headline float percentage implies.

Setup & Price Structure

The 2026-08-21 close of $19.59 sits 31.5% below the 52-week high of $28.58 on the split/dividend-adjusted series used to grade levels here. Two shelves have failed in sequence — $22 on 2026-08-14, $20 on 2026-08-21 — and nothing above the current price has been reclaimed on a weekly close since the 2026-08-06 print reaction faded.

Two things about the structure are worth separating. Measured: the shares are still up 3.5% over three months, so the August decline has not yet unwound the full summer advance. Inferred: that leaves an unfinished round-trip below the current price, and the mid-July advance's origin zone is the region a continuation would target.

No base has formed. RSI(14) at 4.6 is an oscillator floor, not a structure — it tells you the selling has been relentless, not that it has stopped. The first observable that would begin a base is a weekly close back above the broken $20 area followed by a higher weekly low; neither exists on the data through 2026-08-21.

Crowding and positioning observables (stated, not judged): reported shares short 13.73M, 74.72% of float, 9.20 days to cover (stockanalysis.com, 2026-08-23), up from 10.93M reported in the prior August reading; 40.67M shares outstanding, so single blocks and index flows can set the price for multiple sessions; a target raise to $30 on 2026-08-17 and a Sell-rated $22 both sitting above the last close; and no earnings date inside the next 30 days, with the most recent report on 2026-08-06 after the close.

Catalyst Calendar (next 30 days)

• ~2026-08-31 (est.) — FINRA short-interest settlement date for the second August period. Sets the reading that shows whether the 13.73M-share base kept building through the $20 break.
• ~2026-09-09 (est.) — Publication of that settlement. The only near-term positioning datapoint in the window; a materially reduced base without price recovery removes the fuel behind any large up-day.
• ~2026-09-18 (est.) — Quarterly index-review effective date. Much smaller than the June 2026 Russell Value reclassification that drove the 2026-07-16 +10% move, but it is the only scheduled flow event before the Q3 print.
• ~2026-09-24 (est.) — Publication of the mid-September short-interest settlement, the second positioning read inside the window.
• Note what is not in the window: the Q3 2026 report (~2026-11-05, est.) sits outside it. Roughly ten weeks of dead air separate the last failed level from the next fundamental test.

What Would Change Our Mind

The structure that would have to appear first is a weekly close back above the broken $22 shelf, paired with a FINRA settlement showing the 13.73M-share short base materially reduced — covering into strength rather than the reverse. On the fundamentals, Q3 billings landing inside the guided +4–6% after two consecutive −1% quarters would restore the back-half inflection the FY26 +3–5% guide depends on, and Q3 adjusted EBITDA at the guided $19–21M against the $14.8M just reported would show the late-May cost programme reaching the reported line.

Running the other way, a weekly close below $18 extends the August slide past the mid-July index-inclusion advance and ends the last remaining constructive case here — that a 74.72%-of-float short base against 40.67M shares outstanding forces a covering bounce off the RSI(14) 4.6 extreme. A second confirming condition would be a short-interest settlement showing shares short still above 13.73M with the price under $20: supply rebuilding rather than covering.

A downward revision to the $513–523M FY26 revenue range, or a second major firm joining Goldman at Sell, would remove the fundamental leg the drawdown is currently being defended on.

Correlation Notes

• The name trades with the high-short-interest micro-cap cohort more than with local-commerce peers. With 40.67M shares outstanding and 9.20 days to cover, index-review and block flows dominate short-horizon price formation — the 2026-07-16 +10% session on the Russell Value reclassification is the clearest dated instance.
• Convertible-linked hedging is a live cross-current: $290.281M of convertible principal outstanding at 2026-06-30, of which $244.071M is the 4.875% 2030 issue. Some of the reported short interest is likely delta hedge rather than a directional bet — inferred from the capital structure, not measured — which weakens the read-across from float percentage to squeeze potential.
• Fundamentally the exposure is North American local services demand; NA local billings printed −1% YoY in Q2 2026, so consumer-discretionary datapoints on local and experiential spend are the relevant macro tape between now and the Q3 report.
• Sell-side is not a correlated bloc here: Northland at $30 (2026-08-17) and Goldman Sachs at $22 with a Sell (August 2026) are modelling the same guide to opposite conclusions, which is why single notes have moved this stock in the past.